Clinical Trial Update: Temocillin Pharmacokinetic in Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 study assessing the pharmacokinetics of temocillin in patients undergoing hemodialysis, in the setting of Gram-negative bacterial infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease Requiring Hemodialysis
• Gram-negative Bacterial Infections

Drugs mentioned

• Temocillin (temocillin)

Snippet

Sponsor: AZ Sint-Jan AV | Conditions: Gram-Negative Bacterial Infections, Renal Failure Chronic Requiring Hemodialysis | Phase 4 | Status: COMPLETED